TARGET-seq: Linking single-cell transcriptomics of human dopaminergic neurons with their target specificity

Alessandro Fiorenzano,Petter Storm,Edoardo Sozzi,Andreas Bruzelius,Sara Corsi,Janko Kajtez,Janitha Mudannayake,Jenny Nelander,Bengt Mattsson,Malin Åkerblom,Tomas Björklund,Anders Björklund,Malin Parmar
DOI: https://doi.org/10.1073/pnas.2410331121
2024-11-19
Abstract:Dopaminergic (DA) neurons exhibit significant diversity characterized by differences in morphology, anatomical location, axonal projection pattern, and selective vulnerability to disease. More recently, scRNAseq has been used to map DA neuron diversity at the level of gene expression. These studies have revealed a higher than expected molecular diversity in both mouse and human DA neurons. However, whether different molecular expression profiles correlate with specific functions of different DA neurons or with their classical division into mesolimbic (A10) and nigrostriatal (A9) neurons, remains to be determined. To address this, we have developed an approach termed TARGET-seq (Tagging projections by AAV-mediated RetroGrade Enrichment of Transcriptomes) that links the transcriptional profile of the DA neurons with their innervation of specific target structures in the forebrain. Leveraging this technology, we identify molecularly distinct subclusters of human DA neurons with a clear link between transcriptome and axonal target-specificity, offering the possibility to infer neuroanatomical-based classification to molecular identity and target-specific connectivity. We subsequently used this dataset to identify candidate transcription factors along DA developmental trajectories that may control subtype identity, thus providing broad avenues that can be further explored in the design of next-generation A9 and A10 enriched DA-neurons for drug screening or A9 enriched DA cells for clinical stem cell-based therapies.
What problem does this paper attempt to address?